Clinical trial
Stereotactic Laser Ablation for Temporal Lobe Epilepsy (Slate)
NCT02844465 · MedtronicNeuro, Industry · Completed
Key facts
| NCT number | NCT02844465 |
|---|---|
| Title | Stereotactic Laser Ablation for Temporal Lobe Epilepsy (Slate) |
| Official title | Stereotactic Laser Ablation for Temporal Lobe Epilepsy |
| Acronym | SLATE |
| Lead sponsor | MedtronicNeuro, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Temporal Lobe Epilepsy |
| Intervention type | Device |
| Interventions | Visualase MRI-Guided Laser Ablation |
| Enrollment | 167 |
| Start date | Dec 1, 2016 |
| Primary completion | Dec 11, 2023 |
| Completion | Dec 11, 2023 |
| First posted | Jul 26, 2016 |
| Last update posted | Jan 17, 2025 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: